Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Combination therapy with Notch and PI3K/mTOR inhibitors for use in treating cancer

Combination therapy with Notch and PI3K/mTOR inhibitors for use in treating cancer

US Patent 11564929 · Granted Jan 31, 2023

Estimated economic value: $1,956,306,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Non-recombinant human insulin-like growth factor binding protein concentrate2024
Combination therapy with notch and PD-1 or PD-L1 inhibitors2023
Combination therapy with Notch and CDK4/6 inhibitors for the treatment of cancer2022
(E)-1-(4-(dimethylamino)but-2-enoyl)pyrrolidin-3-yl 4-((3-isopropyl-5-methylpyra2020
Combination therapy with Notch and PD-1 or PD-L1 inhibitors2020
Notch pathway signaling inhibitor compounds2019
Disubstituted phthalazine hedgehog pathway antagonists2015
Disubstituted phthalazine hedgehog pathway antagonists2012
Modulation of survivin expression2009
Attenuated and dominant negative variant cDNAs of Stat6: Stat6b and Stat6c2002
Immobilization of biologically active molecules by changing the Oxidation state 1995
Topical use of IGF-II for wound healing1989